Leveraging an AI-powered omnimodal foundation model to accelerate drug discovery, optimize patient stratification, and de-risk clinical developmentWALTHAM, Mass.--(BUSINESS WIRE)--BostonGene, a ...
Eight studies demonstrate how clinically relevant models and integrated data can reduce translational risk and guide development decisions HACKENSACK, NJ / ACCESS Newswire / April 9, 2026 / Champions ...
Neuro-symbolic, multi-agent AI system achieves 4x faster trial matching with oncologist-confirmed accuracy across 17,000+ ...
NantBioRenewables, the company behind the Wave Ware™ line of high-performance renewable foodservice products, today announced the expansion of its U.S. manufacturing capabilities in Gadsden, Alabama, ...
Behavior Labs launches a decision intelligence platform that gives pharma, biotech, and medical device teams continuous competitive and market intelligence and scenario modelling — replacing quarterly ...
Activ provides real-time visualization and now offers digital integration with the Stealth AXiS surgical navigation system, ...
Bristol Myers Squibb partners with Faro Health to deploy AI driven protocol design, aiming to streamline clinical trials, improve efficiency and accelerate drug development through structured data and ...
Accuris today announced the launch of the Accuris AI Assistant, a new capability that gives engineers direct, citation-backed answers from licensed standards and technical content - embedded directly ...
Gigascale Capital, a venture firm founded by Mike Schroepfer that backs early-stage companies rebuilding the physical economy with solutions that, at scale, are cheaper, more productive, and less ...
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced a strategic collaboration ...
Preliminary Q1 2026 net product revenue of approximately $44.2 million, representing an ~168% year-over-year increase ...
NR is the first among NR, NMN, and NAD+ to receive a pharmacopeial quality benchmark, reinforcing Niagen Bioscience’s leadership in NAD+ science and ingredient qualityLOS ANGELES--(BUSINESS ...
一部の結果でアクセス不可の可能性があるため、非表示になっています。
アクセス不可の結果を表示する